Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation - Poll - MDSpire

Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation

  • By

  • Jan Smeitink

  • Just van Es

  • Brigitte Bosman

  • Mirian C H Janssen

  • Thomas Klopstock

  • Grainne Gorman

  • John Vissing

  • Gerrit Ruiterkamp

  • Chris J Edgar

  • Evertine J Abbink

  • Rob van Maanen

  • Oksana Pogoryelova

  • Claudia Stendel

  • Almut Bischoff

  • Ivan Karin

  • Mahtab Munshi

  • Anne Kümmel

  • Lydia Burgert

  • Christianne Verhaak

  • Herma Renkema

  • November 6, 2024

  • 0 min

Share

Original Source(s)

Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation

  • by Jan Smeitink, Just van Es, Brigitte Bosman, Mirian C H Janssen, Thomas Klopstock, Grainne Gorman, John Vissing, Gerrit Ruiterkamp, Chris J Edgar, Evertine J Abbink, Rob van Maanen, Oksana Pogoryelova, Claudia Stendel, Almut Bischoff, Ivan Karin, Mahtab Munshi, Anne Kümmel, Lydia Burgert, Christianne Verhaak, Herma Renkema

  • November 6, 2024

Related Content

Harsh discipline mediates the association between parenting stress and internalizing problems in children and adolescents: survey-based and online intervention evidence

Effectiveness of mindfulness-based stress reduction for depression in post-stroke patients: a systematic review and meta-analysis

Late-life difficult-to-treat depression and dementia subtypes: a naturalistic cohort study using electronic health records